Search
Powered By HealthLine
Special Offers
Health Tools
 Food Guide
 Cooking Tools & Calculators
 Diet Reviews
 Eat Out Smart
 Healthy Cooking
Featured Conditions
 Diet & Exercise
 Food & Fitness
 High Blood Pressure
 Cholesterol
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Caffeine Therapy Boosts Preemies' Outcomes

It cut their risk for neurodevelopmental trouble, researchers say

By Serena Gordon
HealthDay Reporter


Related Encyclopedia
 border=
Abdominoplasty
Acidophilus
Acne
Acoustic Neurinoma
More...

Related Healthscout Videos
 border=
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
When's the Next Free Mammogram Day? October 17, 2008!!!
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Dental Cavities
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Adderal XR
Cialis
Concerta
More...

Related News Articles
 border=
Semi-Annual Time Changes May Affect the Heart
FDA Faulted for Stance on Chemical in Plastics
Family Halloween Safety Can Be Fiendishly Simple
Health Tip: Help Prevent Infertility
More...

WEDNESDAY, Nov. 7 (HealthDay News) -- Some adults joke they couldn't live without their morning coffee, but caffeine may be literally life-changing if given as treatment to tiny premature infants.

New research finds that high doses of caffeine therapy given to babies born very early -- an average of 27 weeks gestation -- reduced their risk of serious disabilities, including cerebral palsy.

Text Continues Below



"This is really good news for caregivers and parents. We now know that caffeine is definitively a treatment where the benefits outweigh the harms," said the study's lead author, Dr. Barbara Schmidt, a professor in the department of clinical epidemiology and biostatistics at McMaster University in Hamilton, Ontario, Canada. "This is actually the first drug that has been convincingly shown to reduce disability rates in these children," she added.

Schmidt's team published its findings in the Nov. 8 issue of the New England Journal of Medicine.

About 12 percent of American babies are born prematurely, according to the March of Dimes. The earlier a baby is born -- normal gestation is 40 weeks, and anything before 37 weeks is considered premature -- the more likely that baby is to have serious disabilities if he or she survives.

Because the odds are often against the tiniest babies, neonatologists quickly put into practice treatments they think might help premature infants survive with the fewest disabilities. Studies on the efficacy of such treatments often follow, and that's the case with caffeine therapy. According to Dr. Beverly Brozanski, clinical director of neonatology at Children's Hospital of Pittsburgh, caffeine therapy has been used to treat premature infants for about 10 years.

To answer the question of whether or not caffeine therapy was helping or harming premature infants with a condition known as apnea of prematurity, Schmidt and her colleagues followed a group of a little more than 2,000 infants from Canada, Australia and the United Kingdom. Apnea literally means the temporary cessation of breathing, and apnea of prematurity is a common condition in premature babies, because their lungs and central nervous system aren't yet properly developed.

Page:  1 | 2 | 3 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 11/7/2007

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Barbara Schmidt, M.D., professor, department of clinical epidemiology and biostatistics, McMaster University, Hamilton, Ontario, Canada, and professor of pediatrics and Knisely chair in neonatology, Children's Hospital of Philadelphia; Beverly Brozanski, M.D., clinical director of neonatology, Children's Hospital of Pittsburgh, and professor of pediatrics University of Pittsburgh; Nov. 8, 2007, New England Journal of Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map